Sign in
4

Changes in Ownership

CytomX Therapeutics, Inc. Filed Acc 0001140361-16-087008

Director sold 51,581 shares at an average $11.50 ($593,428)

From the SEC's structured data for this filing

Trades in this filing

SHANNON TIMOTHY M · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2016-11-15 Sale : show line 1 in the form −33,064 $11.48 $379,476 3,811,317 I
2016-11-16 Sale : show line 2 in the form −18,517 $11.55 $213,953 3,792,800 I
Open-market sales · 51,581 sh · avg $11.50 · $593,428
Loading xslF345X03/doc1.xml…